Use the Back button in your browser to see the other results of your search or to select another record.
Baduanjin for ischemic heart failure with mildly reduced/preserved ejection fraction (BEAR Trial): a randomized controlled trial |
Li J, Yu M, Wang Y, Li S, Li S, Feng X, Li R, Chen K, Xu H |
Journal of Evidence-Based Medicine 2024 Sep;17(3):526-534 |
clinical trial |
8/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
Copyright release for this abstract has not been granted.
|